J Korean Soc Study Obes.  2004 Jun;13(2):110-120.

The Effect of Rosiglitazone on Insulin Sensitivity Through Change of Concentrations of Adipocytokine and Low Density Muscle

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. acw@yumc.yonsei.ac.kr
  • 221th Century Diabetes and Vascular Research Institute, Korea.

Abstract

BACKGROUND: This study was to investigate the new mechanism of rosiglitazone in skeletal muscle to improve insulin resistance through relationship between concentrations of adipocytokine and mid thigh low density muscle area.
METHODS
Forty two type 2 diabetic patients(age: 32~70 years old, BMI 17.48~32.55kg/m2, 15 women, 27 men) were enrolled in this study, and designed as rosiglitazone 4mg, administered daily for 12 weeks. We assessed body composition, and measured the level of plasma adiponectin, leptin, resistin and various biochemical parameters.
RESULTS
Twelve weeks of 4mg/day rosiglitazone treatment improved insulin resistance(IR, as measured using the Kitt: from 2.52+/-0.98 to 2.85+/-1.11%/min, p<0.05). Plasma adiponectin levels increased from 5.58+/-2.19 to 8.80+/-3.02microgram/mL(p<0.01). Plasma leptin levels decreased but did not change significantly (7.47+/-6.44 to 6.63+/-4.06pg/mL, p=0.10). Plasma resistin levels decreased from 3.23+/-2.46 to 1.91+/-1.93microgram/mL(p<0.01). Cross sectional area of low density muscle(LDM) at the mid thigh was positively correlated with insulin resistance. However any concentration of adipocytokines we measured was not associated with insulin resistance in this study.
CONCLUSION
We found that improvement of insulin resistance by rosiglitazone treatment was not associated with change of mid thigh low density muscle and concentrations of adipocytokines. We should consider that our subjects were relatively well obese and their insulin resistance was not severe. We also postulated that other factor rather than accumulation of fatty acid metabolite in skeletal muscle may be much more important in regard to change of insulin resistance with rosiglitazone treatment. It is also possible the effects of rosiglitazone on low density muscle may be different in Korean patients with type 2 DM.

Keyword

Rosiglitazone; Insulin Resistance; Adiponectin; Leptin; Resistin; Low density muscle

MeSH Terms

Adipokines
Adiponectin
Body Composition
Female
Humans
Insulin Resistance*
Insulin*
Leptin
Muscle, Skeletal
Plasma
Resistin
Thigh
Adipokines
Adiponectin
Insulin
Leptin
Resistin
Full Text Links
  • JKSSO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr